Skip to main content

Can-Fite BioPharma Ltd.

CANF
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001536196

No open-market purchases or sales by Can-Fite BioPharma Ltd. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $149.1K in total; no superinvestor holds it.

Superinvestors holding CANF, Q2 2026

See all superinvestors

No superinvestor reported holding CANF in Q2 2026.